Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

A clinical study of V940 in people with non-small cell lung cancer (V940-013) Recruiting

2025-520902-37-00 Non-small cell lung cancer stage IV 2026-04-01
Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Treatment with Eribulin or Vinorelbine or Capecitabine Versus Eribulin or V… Recruiting

2025-521966-91-00 Refractory Metastatic Breast Cancer with Liver Dominant 2026-03-31
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have … Recruiting

2025-521730-28-00 Colorectal Cancer with Cancer Cachexia 2026-03-30
A Phase IIb Study to Determine the Safety, Tolerability and Efficacy of a Daily Oral Dose of SCI-110 in Adult Patients with Tourette's Syndr… Recruiting

2024-512949-17-00 Tourette's syndrome in adults (≥18 and ≤65 years) in ou 2026-03-26
A Phase 2, randomized, multicenter, open-label neoadjuvant study evaluating zanidatamab in combination with chemotherapy in participants wit… Recruiting

2025-523204-68-00 HER2-positive breast cancer 2026-03-25
Chlorhexidine and/or metronidazole plus FB301 pre-treatment trial Recruiting

2025-524362-20-00 Bacterial vaginosis 2026-03-23
A study to investigate efficacy, safety, immunogenicity, and pharmacokinetics of GSK3862995B following repeat doses in participants with bro… Recruiting

2025-522892-27-00 Bronchiectasis 2026-03-21
MP: ADAPT Forward - Master protocol of a platform study to evaluate the safety and efficacy of multiple regimens in participants with Myasth… Recruiting

2025-522492-28-00 AChR-Ab Seropositive Generalized Myasthenia Gravis, Mya 2026-03-13
A Phase 2, Multi-center, Randomized, Dose-Ranging, Placebo-Controlled, Double-blind Study of the Relaxin Agonist R2R01 in Patients at High R… Recruiting

2025-523037-25-00 Patients at high risk for Cardiac Surgery Associated – 2026-03-10
Visugromab, nivolumab and lenvatinib compared to double placebo and lenvatinib in unresectable or metastatic hepatocellular carcinoma post a… Recruiting

2025-520675-86-00 Unresectable or Metastatic Hepatocellular Carcinoma and 2026-03-10
A single-arm phase II-study to confirm efficacy and feasibility of tarlatamab treatment in patients with extensive stage small-cell lung can… Recruiting

2025-522437-65-00 small-cell lung cancer 2026-03-06
A clinical study of new treatments for non-small cell lung cancer (MK-3475-01J) Recruiting

2025-521939-36-00 Participants with KRAS G12C-Mutant, Advanced or Metasta 2026-03-03
Tildrakizumab, an Anti-IL-23 Antibody for the Treatment of Refractory Chronic Spontaneous Urticaria – a single-arm, open-label, phase II stu… Recruiting

2024-513155-32-00 chronic spontaneous urticaria 2026-03-02
TADalafil in early-stage Parkinson’s Disease (TAD-PD) Recruiting

2025-521819-39-00 Parkinson's disease 2026-03-02
PASSION (olaParib mAintenance in chemotherapy-Sensitive metaStatic pancreatIc adenOcarciNoma - mPDAC): a phase II, proof of principle, study Recruiting

2025-522530-31-01 Patients with metastatic PDAC, who have not progressed 2026-02-27
Testosterone Replacement Therapy in Women with Turner Syndrome Recruiting

2024-517755-12-00 Turner Syndrome 2026-02-26
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety … Recruiting

2024-520098-12-00 Cutaneous Lupus Erythematosus 2026-02-16
LUSPARA - Luspatercept in patients affected with rare inherited anemias Recruiting

2024-520200-26-00 Inherited anemias 2026-02-13
PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAMIZESTRANT PLUS RIBOCICLIB IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE (HR+) BREAST C… Recruiting

2024-520027-88-00 Patients with hormone receptor-positive (HR+) breast ca 2026-02-12
Testosterone intake in supportive care patients: impact on quality of life. Recruiting

2025-522023-10-00 Androgen deficiency, palliative care 2026-02-11
Zasocitinib in Nonsegmental Vitiligo Recruiting

2025-522309-40-00 Non-segmental vitiligo 2026-02-11
A Multi-Stage Study to Test a New Drug in Healthy Adult Volunteers, Then in Adults with Ulcerative Colitis Recruiting

2025-522702-21-00 Ulcerative Colitis is a type of inflammatory bowel dise 2026-01-26
A Phase 2 Study of PTX-100 Monotherapy in Patients with r/r CTCL Recruiting

2025-521852-45-00 Cutaneous T-Cell Lymphoma 2026-01-22
Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 Newly Diagnosed Multiple Myeloma 2026-01-08